Chimeric Antigen Receptor (CAR) T-cell Therapy

Can commoners afford to spend million dollars on GENE Therapy?

Articles, Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, DelveInsight's Drug Report, Pharma Consultant

Each country has a unique system, politics, and economy. Different policies are designed to suit people of different countries. Same goes...

Read More

The Business Cocktail

Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, Pharma Consultant

BridgeBio bags USD 299 Million for genetic diseases BridgeBio Pharma has received a USD299.2 million for its progress in genetic...

Read More

Is Gene Therapy the Next Cancer Treatment Revolution? 

Articles, Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, Gene Therapy Products, Pharma Consultant • 4 Comments

Gene Therapy is now touted as a new revolution for cancer treatment. If the list of new cancer treatment methodologies is traversed, then...

Read More
Close